4//SEC Filing
CytomX Therapeutics, Inc. 4
Accession 0001140361-15-046030
$CTMXCIK 0001501989operating
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 1:01 PM ET
Size
7.0 KB
Accession
0001140361-15-046030
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2015-12-31−8,917→ 76,688 totalExercise: $6.61Exp: 2025-08-25→ Common Stock (8,917 underlying) - Exercise/Conversion
Common Stock
2015-12-31$6.61/sh+8,917$58,983→ 13,917 total
Footnotes (1)
- [F1]This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501989
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 1:01 PM ET
- Size
- 7.0 KB